The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Abstract
INTRODUCTION: Drug-drug interactions (DDIs) arise in numerous different ways, involving pharmacokinetic or pharmacodynamic mechanisms. Adverse drug reactions are a possible consequence of DDIs and health operators are often unaware of the clinical risks of certain drug combinations. Many papers on drug interactions have been published in recent years, but most of them focused on potential DDIs while few studies have been conducted on actual interactions. AREAS COVERED: This paper reviews the epidemiology of actual DDIs in outpatients as well as in hospital settings and in spontaneous reporting databases. The incidence of actual DDIs is consistently lower than that of potential DDIs. However, the absolute number of patients involved is high, representing a significant proportion of adverse drug reactions. The importance of risk factors such as age, polypharmacy and genetic polymorphisms is also evaluated. The relevance and efficacy of tools for recognizing and preventing DDIs are discussed. EXPERT OPINION: Potential DDIs far outnumber actual drug interactions. The potential for an adverse interaction to occur is often theoretical, and clinically important adverse effects occur only in the presence of specific risk factors. Several studies have shown the efficacy of computers in early detection of DDIs. However, a correct risk-benefit evaluation by the prescribing physician, together with a careful clinical, physiological and biochemical monitoring of patients, is essential. Future directions of drug interaction research include the increasing importance of pharmacogenetics in preventing DDIs and the evaluation of interactions with biological drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809171 · Cited by 2,497
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
Polypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,265
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A. (2003) · JAMA · doi:10.1001/jama.289.13.1652 · Cited by 761
Bormate, A. B., Leboit, P. E., & McCalmont, T. H. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.8.1020 · Cited by 731
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
Fialová, D. (2005) · JAMA · doi:10.1001/jama.293.11.1348 · Cited by 707
Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041888 · Cited by 702
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004439 · Cited by 692
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Hospital Admissions Resulting from Preventable Adverse Drug Reactions
McDonnell, P. J., & Jacobs, M. R. (2002) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2002)036<1331:harfpa>2.0.co;2 · Cited by 587
The challenge of managing drug interactions in elderly people
Mallet, L., Spinewine, A., & Huang, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61092-7 · Cited by 537
Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02744.x · Cited by 537
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Inappropriate Medication is a Major Cause of Adverse Drug Reactions in Elderly Patients
LINDLEY, C. M., TULLY, M. P., PARAMSOTHY, V., & TALLIS, R. C. (1992) · Age and Ageing · doi:10.1093/ageing/21.4.294 · Cited by 389
HALLAS, J., HARVALD, B., GRAM, L. F., GRODUM, E., BRØSEN, K., HAGHFELT, T., & DAMSBO, N. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00199.x · Cited by 377
Integrating genotype and phenotype information: an overview of the PharmGKB project
Klein, T. E., Chang, J. T., Cho, M. K., Easton, K. L., Fergerson, R., Hewett, M., Lin, Z., Liu, Y., Liu, S., Oliver, D. E., et al. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500035 · Cited by 360
Passarelli, M. C. G., Jacob-Filho, W., & Figueras, A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522090-00005 · Cited by 343
Hospitalisations and emergency department visits due to drug–drug interactions: a literature review
Becker, M. L., Kallewaard, M., Caspers, P. W., Visser, L. E., Leufkens, H. G., & Stricker, B. H. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1351 · Cited by 333
Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population
Goldberg, R. M., Mabee, J., Chan, L., & Wong, S. (1996) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(96)90147-3 · Cited by 319
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008
Hovstadius, B., Hovstadius, K., Åstrand, B., & Petersson, G. (2010) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-10-16 · Cited by 290
Discrepancies in the Use of Medications: Their Extent and Predictors in an Outpatient Practice
Bedell, S. E., Jabbour, S., Goldberg, R., Glaser, H., Gobble, S., Young-Xu, Y., Graboys, T. B., & Ravid, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2129 · Cited by 279
Köhler, G. I., Bode-Böger, S. M., Busse, R., Hoopmann, M., Welte, T., & Böger, R. H. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38504 · Cited by 271
Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents
Nguyen, J. K., Fouts, M. M., Kotabe, S. E., & Lo, E. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.03.002 · Cited by 265
Bates, E. R., Lau, W. C., & Angiolillo, D. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.024 · Cited by 231
Drug related admissions to medical wards: a population based survey.
Hallas, J., Gram, L., Grodum, E., Damsbo, N., Brosen, K., Haghfelt, T., Harvald, B., Beck‐ Nielsen, J., Worm, J., & Jensen, K. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04001.x · Cited by 201
Potential drug–drug interactions in the medication of medical patients at hospital discharge
Egger, S. S., Drewe, J., & Schlienger, R. G. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0557-z · Cited by 195
Haider, S. I., Johnell, K., Thorslund, M., & Fastbom, J. (2007) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45643 · Cited by 192
Tamblyn, R. M., McLeod, P. J., Abrahamowicz, M., & LaPrise, R. (1996) · Europe PMC (PubMed Central) · Cited by 190
Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?
Gurwitz, J. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1957 · Cited by 190
Doucet, J., Chassagne, P., Trivalle, C., Landrin, I., Pauty, M. D., Kadri, N., Ménard, J. F., & Bercoff, E. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01865.x · Cited by 189
Suspected adverse drug events requiring emergency department visits or hospital admissions
Raschetti, R., Morgutti, M., Menniti-Ippolito, F., Belisari, A., Rossignoli, A., Longhini, P., & La Guidara, C. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050582 · Cited by 183
Mikus, G., SCHOWEL, V., Drzewinska, M., Rengelshausen, J., DING, R., RIEDEL, K., Burhenne, J., WEISS, J., Thomsen, T., & Haefeli, W. E. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.04.004 · Cited by 157
Drug-Drug Interactions in a Geriatric Outpatient Cohort: Prevalence and Relevance
Tulner, L. R., Frankfort, S. V., Gijsen, G. J. P. T., van Campen, J. P. C. M., Koks, C. H. W., & Beijnen, J. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825040-00007 · Cited by 141
Saverno, K. R., Hines, L. E., Warholak, T. L., Grizzle, A. J., Babits, L., Clark, C., Taylor, A. M., & Malone, D. C. (2010) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2010.007609 · Cited by 137
Exposure to potential drug interactions in primary health care
Bjerrum, L., Andersen, M. T., Petersen, G., & Kragstrup, J. (2003) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310001806 · Cited by 133
Drug-related emergency department visits and hospital admissions
Prince, B. S., Goetz, C. M., Rihn, T. L., & Olsky, M. (1992) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/49.7.1696 · Cited by 131
Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
Gruer, P. J. K., Vega, J. M., Mercuri, M. F., Dobrinska, M. R., & Tobert, J. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00442-7 · Cited by 130
Doubova, S. V., Reyes‐Morales, H., Torres‐Arreola, L. D. P., & Suárez-Ortega, M. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-147 · Cited by 128
Drug-related deaths in a university central hospital
Juntti‐Patinen, L., & Neuvonen, P. J. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0501-2 · Cited by 127
Davies, E. C., Green, C. F., Mottram, D. R., Rowe, P., & Pirmohamed, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03751.x · Cited by 125
The Dosing of Atypical Antipsychotics
de León, J., Armstrong, S. C., & Cozza, K. L. (2005) · Psychosomatics · doi:10.1176/appi.psy.46.3.262 · Cited by 124
Frequency of Hospitalization after Exposure to Known Drug‐Drug Interactions in a Medicaid Population
Hamilton, R. A., Briceland, L. L., & Andritz, M. H. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03942.x · Cited by 119
Vonbach, P., Dubied, A., Krähenbühl, S., & Beer, J. H. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.12.002 · Cited by 119
Drug interactions and multiple drug administration
May, F. E., Stewart, R. B., & Cluff, L. E. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977223322 · Cited by 113
Adverse Drug Reactions and Drug Interactions as Causes of Hospital Admission in Oncology
Miranda, V. D. C., Fêde, Â., Nobuo, M., Ayres, V. J., del Giglio, A., Miranda, M. D. C., & Riechelmann, R. P. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.11.014 · Cited by 105
Adverse Drug Events Associated with Hospital Admission
Peyrière, H., Cassan, S., Floutard, E., Rivière, S., Blayac, J., Hillaire‐Buys, D., Quellec, A. L., & Hansel, S. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c126 · Cited by 102
Drug Interaction and Pharmacist
Ansari, J. A. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.66807 · Cited by 99
Leone, R., Magro, L., Moretti, U., Cutroneo, P. M., Moschini, M., Motola, D., Tuccori, M., & Conforti, A. (2010) · Drug Safety · doi:10.2165/11534400-000000000-00000 · Cited by 98
Self-citationBertsche, T., Pfaff, J. A. R., Schiller, P., Kaltschmidt, J., Pruszydlo, M. G., Stremmel, W., Walter‐Sack, I., Haefeli, W. E., & Encke, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1778-8 · Cited by 97
Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions
Madadi, P., Hildebrandt, D., Gong, I. Y., Schwarz, U. I., Ciszkowski, C., Ross, C. J., Sistonen, J., Carleton, B., Hayden, M. R., Lauwers, A. E., et al. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1907 · Cited by 95
Drug-related illness in emergency department patients
Dennehy, C. E., Kishi, D. T., & Louie, C. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.12.1422 · Cited by 95
Dormann, H., Criegee‐Rieck, M., Neubert, A. C., Egger, T., Geise, A., Krebs, S., Schneider, T., Levy, M., Hahn, E. G., & Brune, K. (2003) · Drug Safety · doi:10.2165/00002018-200326050-00004 · Cited by 90
Medication misadventures resulting in emergency department visits at and HMO medical center
Schneitman-McIntire, O., Farnen, T. A., Gordon, N. P., Chan, J., & Toy, W. A. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.12.1416 · Cited by 87
Munger, M. A. (2010) · Drugs & Aging · doi:10.2165/11538650-000000000-00000 · Cited by 86
Torsades de Pointes Occurring in Association With Terfenadine Use
Mathews, D. R. (1991) · JAMA · doi:10.1001/jama.1991.03470170063023 · Cited by 85
Straubhaar, B., hl, S. K. H., & Schlienger, R. G. (2006) · Drug Safety · doi:10.2165/00002018-200629010-00006 · Cited by 83
Clinically Significant Drug Interactions
Ament, P. W., Bertolino, J. G., & Liszewski, J. L. (2015) · The American Pharmacists Association eBooks · doi:10.21019/9781582122403.ch27 · Cited by 81
Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients
Reimche, L., Forster, A. J., & van Walraven, C. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010378858 · Cited by 79
Drug-related admissions to an Australian hospital
Stanton, L. A., Peterson, G. M., Rumble, R. H., et al. (1994) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1994.tb00691.x · Cited by 77
Drug-Drug Interactions in Cardiac and Cardiothoracic Intensive Care Units
Smithburger, P. L., Kane‐Gill, S. L., & Seybert, A. L. (2010) · Drug Safety · doi:10.2165/11532340-000000000-00000 · Cited by 73
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
Ma, T. K. W., Lam, Y., Tan, V. P. Y., & Yan, B. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03949.x · Cited by 63
Aronson, J. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02244.x · Cited by 60
Adverse drug reactions in internal medicine units and associated risk factors
Muñoz-Torrero, J. F. S., Barquilla, P., Velasco, R., Capitán, M. D. C. F., Pacheco, N., Vicente, L., Chicón, J. L., Trejo, S., Zamorano, J. L., & Hernández, A. L. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0866-6 · Cited by 59
Adverse Drug Reactions in Hospitalized Psychiatric Patients
Thomas, M., Boggs, A. A., DiPaula, B. A., et al. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m746 · Cited by 56
Admissions to a medical intensive care unit related to adverse drug reactions
Rivkin, A. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060641 · Cited by 55
Clinical Risk Management in Dutch Community Pharmacies
Buurma, H., Smet, P. A. G. M. D., & Egberts, T. C. G. (2006) · Drug Safety · doi:10.2165/00002018-200629080-00009 · Cited by 54
Tirkkonen, T., & LAINE, K. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.017 · Cited by 54
Strandell, J., & Wahlin, S. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0979-y · Cited by 50
Paediatric adverse drug reaction reporting: understanding and future directions.
Carleton, B., Smith, M. A., Gelin, M. N., & Heathcote, S. (2007) · PubMed · Cited by 48
Analysis of adverse drug reactions for preventability
Ducharme, M. M., & Boothby, L. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01130.x · Cited by 47
Drug‐drug interactions as a determinant of elevated lithium serum levels in daily clinical practice
Wilting, I., Movig, K. L. L., Moolenaar, M., Hekster, Y. A., Brouwers, J. R. B. J., Heerdink, E. R., Nolen, W. A., & Egberts, T. C. G. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00199.x · Cited by 36
Severe Rhabdomyolysis as a Consequence of the Interaction of Fusidic Acid and Atorvastatin
Magee, C. N., Medani, S. A., Leavey, S. F., Conlon, P. J., & Clarkson, M. R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.07.011 · Cited by 30
The incidence and nature of drug-related admissions to hospital
Bhalla, N., Duggan, C. A., & Dhillon, S. (2003) · University of Hertfordshire Research Archive (University of Hertfordshire) · Cited by 29
Prami, T., Ryynänen, A., Vahlberg, T. J., Irjala, K., Klaukka, T., Huupponen, R., & Laine, K. (2008) · Drug Safety · doi:10.2165/00002018-200831030-00004 · Cited by 27
Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting
Hatton, R. C., Rosenberg, A. F., Morris, C. T., McKelvey, R. P., & Lewis, J. R. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p533 · Cited by 25
Glassman, P. A., Belperio, P. S., Lanto, A. B., Simon, B. F., Valuck, R. J., Sayers, J. F. B., & Lee, M. (2007) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m2313 · Cited by 24
Manufacturer??s Drug Interaction and Postmarketing Adverse Event Data
Kraft, W. K., & Waldman, S. A. (2001) · Drug Safety · doi:10.2165/00002018-200124090-00001 · Cited by 11
Drug-drug interactions in hospital.
Mok, H., Mulpeter, K., O'Connor, P., et al. (1991) · PubMed · Cited by 7
Moling, O., Rimenti, G., Pristerà, R., Vedovelli, C., Pagani, L., Spoladore, G., & Mian, P. (2009) · Drug Metabolism Letters · doi:10.2174/187231209789352120 · Cited by 6
Regal, R. E., & Vue, C. O. (2004) · The Consultant Pharmacist · doi:10.4140/tcp.n.2004.1119 · Cited by 2
Cited by
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Noguchi, Y., Tachi, T., & Teramachi, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab347 · Cited by 285
Van De Sijpe, G., Quintens, C., Walgraeve, K., Van Laer, E., Penny, J., De Vlieger, G., Schrijvers, R., De Munter, P., Foulon, V., Casteels, M., et al. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01783-z · Cited by 54
“More specifically, 5–17% of adverse drug events among inpatients are caused by drug–drug interactions (DDIs) [1, 6].”
BackgroundPolenick, C. A., Stanz, S. D., Leggett, A. N., Maust, D. T., Hodgson, N. A., & Kales, H. C. (2020) · The Gerontologist · doi:10.1093/geront/gny130 · Cited by 37
Designing and evaluating contextualized drug–drug interaction algorithms
Chou, E., Boyce, R. D., Balkan, B., Subbian, V., Romero, A., Hansten, P. D., Horn, J. R., Gephart, S., & Malone, D. C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab023 · Cited by 34
Metadata
- Authors
- Magro, L., Moretti, U., & Leone, R.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2011-10-25
- Volume
- 11
- Issue
- 1
- Pages
- 83-94
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2010783249
- Cited by
- 287
- References
- 84
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.